MSKCC, the American Cancer Society, Queens Library, and Queens Cancer Center have launched the Queens Library Healthlink Initiative, a five-year, $2 million federally funded initiative that will help increase access to cancer care among medically underserved communities in Queens.
Nominations are currently being sought for the Paul Marks Prize for Cancer Research, which recognizes outstanding young investigators who have made significant contributions to increase the understanding of cancer or improve the treatment of the disease.
African Americans are 21 percent more likely to die from cancer than white Americans and have the highest cancer death rate of any racial or ethnic group. MSKCC is working to help address this and other racial and ethnic disparities in cancer outcomes through its Office of Diversity Programs in Clinical Care, Research, and Training.
Results from a randomized, Phase III trial led by MSKCC medical oncologist Robert Motzer show that the anti-angiogenic drug Sutent is more effective than conventional chemotherapy treatment when given as an initial therapy for patients with advanced kidney cancer.
A study by a team of MSKCC clinicians has suggested that asking patients to report side effects during cancer treatment could add valuable information to the monitoring and early detection of potentially serious problems, especially during clinical trials.
A team of scientists led by MSKCC cancer biologist Robert Benezra has revealed new insights into the mechanism of tumor formation by boosting levels of the Mad2 gene in mice.
Researchers led by scientists at MSKCC have identified fundamentally novel mechanisms that regulate the function of the tumor suppressor gene PTEN, an antagonist for many cellular growth, proliferation, and survival processes.
Many of the advances in patient care, research, and education at MSKCC are made by young staff members who are just beginning their careers. Three vignettes highlight the contributions of the Center's younger staff members.
News@MSKCC provides journalists with news and information from Memorial Sloan-Kettering Cancer Center and is released six times a year.
For more information about these and other potential story ideas, contact Memorial Sloan-Kettering's Department of Public Affairs at: 212-639-3573 or at mediastaff@mskcc.org
